Income Statement
TENON MEDICAL, INC.
TNON
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY |
|---|---|---|---|---|
|
Revenue
|
4.82 | 3.28 | 2.93 | 0.69 |
|
Cost of Revenue
|
1.59 | 1.57 | 1.69 | 1.33 |
|
Gross Profit
|
2.36 | 1.71 | 1.24 | -0.64 |
|
Operating Expenses
|
15.15 | 15.48 | 16.97 | 18.08 |
|
Research & Development
|
2.15 | 2.60 | 3.16 | 2.83 |
|
Selling, General & Administrative
|
6.98 | 7.77 | 7.03 | 7.83 |
|
Other Operating Expenses
|
- | - | - | - |
|
Operating Income
|
-12.79 | -13.77 | -15.73 | -18.73 |
|
Non-Operating Income
|
0.24 | 0.09 | 0.15 | -0.19 |
|
Interest Income
|
- | - | - | - |
|
Interest Expense
|
- | - | 0.02 | 0.35 |
|
Other Non-Op Income / Expense
|
- | -0.06 | - | - |
|
Income Before Tax
|
- | - | - | -18.92 |
|
Income Tax Expense
|
- | - | - | - |
|
Non-Controlling Interest
|
- | - | - | 0.00 |
|
Net Income
|
-12.56 | -13.67 | -15.58 | -18.92 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY |
|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - |
|
EBITDA
|
-12.53 | -13.36 | -15.53 | -18.73 |
|
Earnings Per Share (Basic)
|
-1.70 | -11.26 | -8.59 | -2.36 |
|
Diluted EPS
|
-1.70 | -11.26 | - | -2.36 |
|
Weighted Average Shares
|
0.01 | 0.00 | 0.00 | 0.01 |
|
Diluted Weighted Avg Shares
|
0.01 | 0.00 | - | 0.01 |
|
Comprehensive Income
|
-12.56 | -13.63 | -15.53 | -18.93 |